Evidence map›Paper›PMID 35326465›Full record

ReviewCells2022

Platelets, a Key Cell in Inflammation and Atherosclerosis Progression.

Ricardo Huilcaman, Whitney Venturini, Lucia Fuenzalida, Angel Cayo, Raul Segovia, Claudio Valenzuela, Nelson Brown, Rodrigo Moore-Carrasco

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Platelet reactivity to adenosine diphosphate andNeurosciences (Riyadh, Saudi Arabia) · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ricardo HuilcamanFaculty of Health Sciences, University of Talca, Talca 3460000, Chile.ORCID 0000-0001-5065-4027
Whitney VenturiniFaculty of Health Sciences, University of Talca, Talca 3460000, Chile.
Lucia FuenzalidaFaculty of Health Sciences, University of Talca, Talca 3460000, Chile.
Angel CayoFaculty of Health Sciences, University of Talca, Talca 3460000, Chile.
Raul SegoviaFaculty of Health Sciences, University of Talca, Talca 3460000, Chile.
Claudio ValenzuelaCenter for Medical Research, Medical School, University of Talca, Talca 3460000, Chile.
Nelson BrownCenter for Medical Research, Medical School, University of Talca, Talca 3460000, Chile.
Rodrigo Moore-CarrascoFaculty of Health Sciences, University of Talca, Talca 3460000, Chile.ORCID 0000-0003-4870-9660
University of Talca · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelets play important roles in thrombosis-dependent obstructive cardiovascular diseases. In addition, it has now become evident that platelets also participate in the earliest stages of atherosclerosis, including the genesis of the atherosclerotic lesion. Moreover, while the link between platelet activity and hemostasis has been well established, the role of platelets as modulators of inflammation has only recently been recognized. Thus, through their secretory activities, platelets can chemically attract a diverse repertoire of cells to inflammatory foci. Although monocytes and lymphocytes act as key cells in the progression of an inflammatory event and play a central role in plaque formation and progression, there is also evidence that platelets can traverse the endothelium, and therefore be a direct mediator in the progression of atherosclerotic plaque. This review provides an overview of platelet interactions and regulation in atherosclerosis.

Indexed as

AtherosclerosisThrombosisBlood PlateletsHemostasisHumansInflammationatherosclerosisinflammationplatelets

Identifiers

PMID35326465
PMCPMC8947573
OpenAlexW4220867257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.